CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Tango Therapeutics Fiscal Q3 2022 Earnings Report | CapyFin

Tango Therapeutics

TNGX · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q4 2025 +36.42%Q3 2025 +0.25%Q2 2025 +4.86%Q1 2025 +17.12%Q4 2024 -6.47%Q3 2024 -45.44%Q2 2024 -1.77%Q1 2024 -0.77%Q4 2023 -9.75%Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 +1.09%

Nov 10, 2022

•

Sep 30, 2022

Tango Therapeutics Q3 2022 Earnings Report

Previous year: $6.79M

Previous year: -$0.28

Previous year: $6.79M

Cash and Equivalents

Previous year: $205M

Previous year: -$42.6M

Previous year: $530M

Tango Therapeutics

Unlock previous datapoints

Tango Therapeutics

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Tango Therapeutics